Clinical trial
Safety and Efficacy of Hybrid Fractional Laser diVa Treatment for Symptoms of Urinary Incontinence
NCT03180372 is registered in ClinicalTrials.gov with Sciton as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Hybrid Fractional Laser diVa Treatment for Symptoms of Urinary Incontinence
- Lead sponsor
- Sciton
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 19, 2017
- Completion date
- November 30, 2019
- Enrollment
- 51 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
stress urinary incontinence, urge incontinence, urinary incontinence